Medical Aesthetic News

 The abdomen. The upper arms. The flanks. However consistently you diet or exercise, some areas simply won't budge. Surgery can feel daunting — and as more people slim down on weight-loss medications only to become newly concerned about their body contour, the measure of a good outcome is shifting from how much you lose to the shape you create. That shift has brought attention to microwave body contouring — a non-surgical way to work on the body's shape. ONDA by DEKA keeps the skin surface cool and protected while delivering heat to the fat layer beneath — an approach designed to address both localized fat and skin laxity. Dr. Dongkeun Lee of O.N Clinic Gangnam sees it as a procedure that focuses on visible body contour rather than the number on the scale. Instead of promising to solve everything in a single session, he stresses that the first step is knowing whether your concern is fat or laxity.  #MedicalAestheticNews #DEKA #ONDA #ONClinicGangnam #DrDongkeunLee ★ Article Lin...

 SHENB's SUNNY is an RF system that combines monopolar and bipolar modes, allowing the energy configuration to be tailored to the treatment area and clinical objective. A key component of the system, the Quasar tip, is built around 25 independently moving RF delivery pins designed to conform closely to facial contours, supporting more consistent energy delivery across curved treatment areas. At SHENB's booth at IMCAS Asia 2026 in Bangkok, Thailand, we met Dr. Rasthawathana Desomchoke, a board-certified dermatologist based in Bangkok who, after relying for years mainly on Western energy-based devices, has shifted the focus of his practice toward Korean RF technology. He shared his insights on what drew his attention to SUNNY and the Quasar tip; the clinical strengths of Korean technology from the perspective of a Thai dermatologist; the changes he has observed in perceived pain and patient comfort during treatment; how confidence in Korean medical aesthetics has grown over the p...

 At the 2026 inaugural academic conference of the Korean Obesity, Regenerative & Aesthetic Society (KORA), we met the leaders steering the society. Held on Sunday, June 28 at Konkuk University Medical Center in Seoul, it was the first public stage for a society not yet six months old, where President Seunghyuck Hong, Vice Presidents Sungeun Yoon and Ran Lee, and Senior Director of General Affairs Seongho Lee spoke about why they founded KORA and where they intend to take it. What they emphasized above all was a young, transparent board that shares and decides every matter together, along with a commitment to establishing standards, principles, and ultimately guidelines rather than following trends. President Hong summed it up as "a society that turns today's trends into tomorrow's guidelines." KORA highlighted a combined 752 years of clinical and academic experience — 435 years in aesthetic procedures and 317 years of academic activity — and announced plans for an...

The same skin booster can lead to different results from one person to the next, and from one session to another. One factor behind that gap is how well the formulation is delivered, and to what depth beneath the skin. Push delivery harder and discomfort tends to follow; ease the discomfort and delivery can weaken. re:H (Curiosis) is a microneedle-based delivery platform built around the patented SSCM™ (Selective Smart Control Microneedle System), which pairs microneedling with controlled positive and negative pressure to support the delivery of surface-applied formulations toward the intended depth, with the aim of reducing procedural discomfort. We spoke with Dr. Hyungeun Cho, Chief Medical Director of Rejuel Clinic Gangnam, about the questions patients ask most: what this means for those wary of injections, what to expect in terms of pain and downtime, and which skin concerns it may suit.  #MedicalAestheticNews #reH #Curiosis #RejuelClinicGangnam #DrHyungeunCho ★ Article Link: h...

 Bluecore Company's Trinity is a diode laser that emits three wavelengths — 755, 808, and 1064 nm — simultaneously. By combining three wavelengths with different penetration profiles and three-level contact cooling, it is designed to support treatment comfort across a broad range of skin tones. Ahead of IMCAS Asia 2026 in Bangkok, we spoke with Dr. Ken Lee of BELLA Clinic, who uses Trinity as a versatile platform in Malaysia's multi-ethnic patient population. Rather than tying it to a single indication, he applies it broadly to improve skin quality and tone and to support rejuvenation. He walked us through his approach to treating patients with diverse skin tones or sensitive skin — conservative initial settings, gradual titration based on the patient's response, three-level contact cooling, and appropriately spaced treatment intervals. He also spoke about the subtle, natural results he sees, his use of Trinity for long-term maintenance and as part of combination protocols,...

 One of the most notable trends in aesthetic medicine today is the shift beyond volumizing fillers toward skin rejuvenation and biostimulation focused on improving skin quality itself. JUVELOOK, from VAIM, is a biostimulator combining PDLLA and HA: the HA provides immediate hydration and volume, while the PDLLA stimulates collagen synthesis over time. Designed for intradermal use, it is a skin booster aimed at improving overall skin quality, including texture and elasticity. In line with the current move toward natural-looking results rather than overfilling, it is drawing attention in Asia and beyond. At the VAIM booth during IMCAS Asia 2026 in Bangkok, Thailand, we spoke with Singapore-based oculoplastic surgeon Dr. Stephanie Young, one of the early users of JUVELOOK in Singapore and Southeast Asia. She shared the product's clinical strengths, her perspective on safety as a surgeon, her interest in combining it with energy-based devices, and her insights on the evolving standing ...

 Dermal fillers have become a widely performed treatment, yet amid concerns about complications and aggressive price competition, patients are more uncertain than ever about which filler to choose, and how. Dr. Junyoung Choi, a plastic surgeon at JY Plastic Surgery Clinic (Seoul, Korea) who has practiced for more than 20 years in Seoul's Apgujeong and Cheongdam districts, says much of the concern surrounding fillers stems less from the products themselves than from cost-cutting and a tendency to inject too much in a single session. What matters, he emphasizes, is not the prestige of a brand name, whether imported or domestic, but whether it is a product with established quality and safety, and whether the physician performing the treatment is sufficiently skilled. In his view, premium Korean HA fillers have now caught up with imported products in quality; what truly matters, he explains, is not letting price be the only factor when choosing a substance that can remain in your body ...

 Humedix held the launch symposium for Elravie Re2O Fine, an ECM booster, in Seoul on June 24. Re2O Fine is a line extension of Re2O, the human acellular dermal matrix (hADM)-based skin booster launched last year that quickly gained traction in the market; with a finer mean particle size of about 50 µm, versus roughly 75 µm for standard Re2O, it targets thin, anatomically delicate areas such as the periorbital region and the neck. Lectures were delivered by Dr. Jeyoung Park of Apgujeong Oracle Dermatology, who also chaired the session, Dr. Hansaem Kim of DOD Dermatology Yongsan, and Dr. Jeongwoo Lee of ELEV Clinic. The three faculty discussed the implications of finer particles for particle count and contact surface area, combination with energy-based devices (EBDs), and region-specific mixing and injection protocols, and the subsequent panel discussion covered everything from why Re2O Fine warrants use as a distinct option to admixtures and combination treatment. Humedix said it w...

 Higher Corporation held the '2026 HILO WAVE Grand Symposium (WAVE: UNFOLDED)' in Seoul on June 27. HILO WAVE is built on Dual-HA (DHC, Dual Hyaluronic Acid Compound), combining non-crosslinked high- and low-molecular-weight hyaluronic acid (HA) with minimally crosslinked HA, and has carved out a new category in the skin booster market. The symposium ran across three sessions, from basic mechanisms to clinical application and practice-focused panel discussions. In Sessions 1 and 2, Drs. Doyoung Rhee, Hyojin Roh, Hyoungmoon Kim, Soeun Kim, Gwahnwoo Cheon, and Jinoh Kim, along with Professor Kyunghee Byun, presented on topics ranging from the biological mechanism and physicochemical properties of Dual-HA to clinical use in the under-eye area, along with exploratory observations in pigmentary concerns and hair loss. In Session 3, with Dr. Kooil Seo as chair, a panel of eight physicians — Drs. Dohoon Kim, Jung Min, Moohyun Son, Hyoseung Jang, Arim Min, Hyochul Shin, Hansaem Kim, an...

 One of the notable trends in aesthetic medicine today is needle-free topical skin boosters — treatments that work on the skin through topical application alone, without needles. PRX-PLUS, developed by Italy's WiQo, is a professional-use topical skin booster formulated around ammonium trichloroacetate (ATCA) — the ammonium salt of trichloroacetic acid — and homocysteic acid (HCA), which WiQo describes as exclusive to PRX-PLUS. Applied without needles or lasers, according to the company ATCA drives dermal remodeling without visible frosting, while HCA adds a cumulative brightening and skin-tone-evening effect. With little downtime or discomfort and expected improvements in skin quality, it is drawing growing interest in the field. At WiQo's IMCAS Asia 2026 symposium in Bangkok, we met with Dr. Alvin M. Jorge and Dr. Guia Theresa Favor Jorge — a Filipino physician couple who use PRX-PLUS in combination with other devices and injectables to amplify results. We spoke with them abou...

 One technology drawing attention in medical aesthetics today is needle-free injection, which delivers active agents into the skin through a high-pressure jet rather than a needle. BAZ BIOMEDIC's CureJet is a widely used needle-free jet injector applied across a range of areas, including post-acne and postoperative scars, pore tightening, and skin firmness. Because it avoids needle puncture, it can reduce downtime and discomfort, and is drawing interest as an option for skin types where pigmentary complications are a clinical concern. At BAZ BIOMEDIC's booth at IMCAS Asia 2026 in Bangkok, we spoke with Japanese dermatologist Dr. Shinji Noda of Ikebukuro Ekimae Noda Dermatology, who has made CureJet a key component of his scar and rejuvenation practice. He shared his perspective on CureJet's clinical strengths, the response among his Japanese patients, and the global competitiveness of Korean medical aesthetics.  #MedicalAestheticNews #BAZBIOMEDIC #CureJet #NeedleFreeInjecto...

 Humedix has launched ELITE 2.0 (Experts Leading Integrated Treatment & Excellence), a restructured KOL program. The kickoff meeting expands and reorganizes the company's previously Elravie filler–centered advisory board (ABM) into a portfolio-wide 'Humedix Clinical Ambassador Council', bringing together eight leading physicians in Korea's aesthetic medicine field. The program is designed around 'HITS (Humedix Integrated Treatment System)' — an initiative that organizes Humedix's core portfolio within a unified integrated-treatment framework, with clinicians building everything from per-product standard guides to site-specific integrated treatment protocols. The first product under study is the ECM booster Elravie Re2O Fine, and chairperson Dr. Hosung Choi of Lieul Seoul Clinic proposed positioning Re2O not through head-to-head comparison but along a separate axis of 'ECM-based tissue reinforcement and regeneration'. Members agreed to pursue a ca...

 On the eve of IMCAS Asia 2026, on June 18, VIOL Medical held the SYLFIRM X APAC Symposium in Bangkok 2026 at the Siam Kempinski Hotel, where key opinion leaders (KOLs) from Korea, Malaysia, and Thailand shared clinical strategies spanning pigmentation, vascular concerns, skin rejuvenation, and selected complication-management scenarios, centered on the dual-wave RF microneedling platform SYLFIRM X. Rather than approaching these concerns as separate treatment categories, the speakers converged on a shared idea: that clinical outcomes hinge less on output intensity alone than on how precisely tissue responses are tailored—through the selection of PW or CW mode, treatment depth, and energy level, together with planned combinations with lasers and skin boosters, according to lesion depth, skin type, and the amount of downtime a patient is willing to accept. In a session moderated by Dr. Lim Ting Song of Malaysia, Dr. Arim Min of Korea (Min&Min Clinic) framed SYLFIRM X as a "core ...

 On the opening evening of IMCAS Asia 2026, held in Bangkok from 19–21 June, Candela hosted an exclusive VIP symposium, "Turning Back the Skin Clock: Strategies in Skin Restoration," where UK and Thai KOLs shared the latest clinical strategies across pigmentary, vascular and skin-tightening indications. Rather than treating these as separate procedures, the speakers agreed that outcomes depend on how wavelength, pulse duration, spot size and degree of invasiveness are combined according to lesion depth, skin phototype and each patient's tolerance for downtime. The UK's Prof. Firas Al-Niaimi led three sessions — Vbeam Pro, PicoWay and Nordlys Mini — outlining precise treatment design guided by wavelength and pulse duration, while Thailand's Dr. Wichai Hongcharu emphasised that pulse duration, rather than wavelength alone, may be more decisive in refractory complex pigmentation and presented a PicoWay-based sequential approach. Thailand's Dr. Rumpa Linpiyawan, w...

 On the eve of IMCAS Asia 2026 (June 19–21, Bangkok), two clinicians from Korea and Indonesia shared their clinical experience treating melasma with the HELIOS 785 PICO (marketed internationally as ‘melaKlear’) at the LASEROPTEK Partners Meeting (LPM) in Bangkok 2026. Melasma is a challenging pigmentary disorder — recurrence is common, and the risk of post-inflammatory hyperpigmentation (PIH) rises in darker skin. The 785 nm picosecond wavelength was presented as offering a clinically useful balance between melanin absorption and penetration relative to 1064 nm and 532 nm. Dr. Seokbae Seo of SeoASong Dermatology (Seoul, Korea) emphasized tailoring treatment to each patient’s skin type and lesion rather than raising energy, while Dr. Chandra Permana of ERHA Clinic (Jember, Indonesia) presented a single-session protocol combined with topical therapy, aimed at achieving an early, visible improvement. LASEROPTEK CEO Changjin Lee also emphasized the company’s identity as a laser-special...

 On the eve of IMCAS Asia 2026 in Bangkok (June 19–21), Bluecore hosted its first overseas partner meeting, the "1st BLUE ALLIANCE DAY in Bangkok." With partners from Asia, the Middle East and the Americas, the company shared technology and preclinical evidence for its new PICOREMAX and the triple-wavelength diode lifting laser Trinity. PICOREMAX was introduced with a focus on its proprietary fractional handpiece "DLA," which Bluecore said combines the strengths of DOE and MLA to add a controlled thermal effect around each micro-beam, while the company presented Trinity as delivering brightening, tightening and lifting in a single pass through simultaneous three-wavelength irradiation. In his congratulatory address, Sangju Lee, MD, president of the Association of Korean Dermatologists and of KOREADERMA 2026, called Bluecore Company "a rising star built on innovation and ambition," while CEO John Kim framed partners not as mere distributors but as an "...

 On the opening evening of IMCAS Asia 2026 (Bangkok, June 19–21), Primoris International brought together Korean and Thai KOLs to share the proposed mechanisms of its P198 exosome line and practical combination know-how at the academic dinner symposium "PRISM (Primoris Symposium Medical Summit) in IMCAS Asia 2026." Exosomes are nanoscale biological signals exchanged between cells, with potential roles in tissue recovery and anti-inflammatory activity — yet because the skin barrier limits penetration by topical application alone, many of the speakers pointed to combination with energy-based devices (EBDs) as key. Dr. Hosung Choi (Lieul Seoul Clinic) shared strategies for pairing microneedle RF with P198 to achieve more than an additive effect; Dr. Santi Jaturawichanant (Thailand) presented an approach using a 1927 nm thulium laser to create an epidermal delivery pathway before applying P198; and Dr. Kyuho Yi (You&I Clinic) outlined a delivery design aimed at reducing pain,...

 Medical Aesthetic News was on the ground at IMCAS Asia 2026. Held on June 19–21 at The Athenee Hotel in Bangkok, Thailand, the 19th edition drew — per the organiser's pre-event figures — around 3,300 attendees, with 230 speakers taking the stage, reaffirming its place as one of the largest aesthetic medicine congresses in the Asia-Pacific. This year's program centered on treatments tailored to Asian morphologies, with regenerative and longevity science emerging as major currents. There was a strong Korean presence in particular: among the 131 official sponsors, 53 were Korean companies — roughly 40% — and Korean firms were prominent in the highest sponsorship tiers, underscoring the momentum of K-Medical Aesthetics. Beyond the booths, though, both the threats and the opportunities facing K-Medical Aesthetics came into view — global premium brands from above, China's volume push from below, and the consolidation of distribution networks on top of that. We sat down on-site w...